Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 202 participants.

Also called NCT07083765

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 202 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07083765
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07083765. Randomized; triple masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2028-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Acronym
RADAR
Condition
Hypertension
Condition
Hypertension,Essential
Intervention (Drug)
Dehydrated Alcohol Injection, USP
Intervention (Procedure)
Sham procedure
Lead sponsor
Ablative Solutions, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07083765
Content hash
4abd69015b40d4e2809af227ce56e6b60f4716a36d71790d69bcdb47724028f5